St. Jude Medical Percutaneous Mitral Valve Repair Study (NCT01500148) | Clinical Trial Compass
CompletedPhase 1
St. Jude Medical Percutaneous Mitral Valve Repair Study
United Kingdom2 participantsStarted 2011-12
Plain-language summary
The purpose of this proof-of-concept study is to assess the relative safety and feasibility of the SJM Percutaneous Mitral Valve Repair (PMVr) Device.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Subject has symptomatic or asymptomatic moderate (2+) or severe (3-4+) mitral regurgitation.
* Subject has an ejection fraction (EF) ≥ 30%.
* Subject is of legal age (≥18 years old).
* Subject is planned to undergo surgical repair or replacement of the mitral valve for symptomatic or asymptomatic posterior leaflet mitral prolapse.
Exclusion Criteria:
* Subject requires a complex mitral valve repair or has isolated anterior prolapse.
* Subject has mitral valve stenosis in which the annulus opening is \<10mm. Subject has valve disease other than mitral which requires surgical intervention.
* Subject requires a concomitant procedure.
* Subject has a pre-existing prosthetic valve in any position.
* Subject had stenting or PCI within 6 months before the planned procedure, or is anticipated to require stenting or PCI within 6 months post-procedure.
* Subject has calcification of the mitral leaflets or annulus which in the medical opinion of the surgical investigator would limit repair and /or implantation of the investigational device.
* Subject has renal insufficiency or is on chronic dialysis.
* Subject has had a cerebral vascular accident (CVA) or transient ischemic attack (TIA) within the past 6 months.
* Subject has a history of endocarditis or has active endocarditis.
* Subject has a history of autoimmune disease.
* Subject has significant known carotid artery disease.
* Subject has an aorto-mitral angle of \<110 degrees.
* Subject has hypertrophic ob…